NS35255/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1998	4
1999	7
2000	3
2001	8
2002	9
2003	8
2004	7
2005	1
2006	1
2007	2
2024	0

1

Oxidative stress in Huntington's disease.

Browne SE, Ferrante RJ, Beal MF. Browne SE, et al. Brain Pathol. 1999 Jan;9(1):147-63. doi: 10.1111/j.1750-3639.1999.tb00216.x. Brain Pathol. 1999. PMID: 9989457 Free PMC article. Review.

2

Progress in pathogenesis studies of spinocerebellar ataxia type 1.

Cummings CJ, Orr HT, Zoghbi HY. Cummings CJ, et al. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434309 Free PMC article. Review.

3

Huntington's disease: prospects for neuroprotective therapy 10 years after the discovery of the causative genetic mutation.

Hersch SM. Hersch SM. Curr Opin Neurol. 2003 Aug;16(4):501-6. doi: 10.1097/01.wco.0000084229.82329.03. Curr Opin Neurol. 2003. PMID: 12869810 Review.

4

Translating therapies for Huntington's disease from genetic animal models to clinical trials.

Hersch SM, Ferrante RJ. Hersch SM, et al. NeuroRx. 2004 Jul;1(3):298-306. doi: 10.1602/neurorx.1.3.298. NeuroRx. 2004. PMID: 15717031 Free PMC article. Review.

5

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.

Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, Ryu H, Langley B, Ratan RR, Ferrante RJ, Beal MF. Gardian G, et al. J Biol Chem. 2005 Jan 7;280(1):556-63. doi: 10.1074/jbc.M410210200. Epub 2004 Oct 19. J Biol Chem. 2005. PMID: 15494404 Free article.

6

Mechanisms of copper ion mediated Huntington's disease progression.

Fox JH, Kama JA, Lieberman G, Chopra R, Dorsey K, Chopra V, Volitakis I, Cherny RA, Bush AI, Hersch S. Fox JH, et al. PLoS One. 2007 Mar 28;2(3):e334. doi: 10.1371/journal.pone.0000334. PLoS One. 2007. PMID: 17396163 Free PMC article.

7

Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF. Matthews RT, et al. J Neurosci. 1998 Jan 1;18(1):156-63. doi: 10.1523/JNEUROSCI.18-01-00156.1998. J Neurosci. 1998. PMID: 9412496 Free PMC article.

8

Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ. Gutekunst CA, et al. J Neurosci. 1999 Apr 1;19(7):2522-34. doi: 10.1523/JNEUROSCI.19-07-02522.1999. J Neurosci. 1999. PMID: 10087066 Free PMC article.

9

Regional and progressive thinning of the cortical ribbon in Huntington's disease.

Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B. Rosas HD, et al. Neurology. 2002 Mar 12;58(5):695-701. doi: 10.1212/wnl.58.5.695. Neurology. 2002. PMID: 11889230

10

Cytochrome C and caspase-9 expression in Huntington's disease.

Kiechle T, Dedeoglu A, Kubilus J, Kowall NW, Beal MF, Friedlander RM, Hersch SM, Ferrante RJ. Kiechle T, et al. Neuromolecular Med. 2002;1(3):183-95. doi: 10.1385/NMM:1:3:183. Neuromolecular Med. 2002. PMID: 12095160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year